Laurie Glimcher | |
---|---|
Born | 1951 (age 72–73) |
Education | Radcliffe College (BS) Harvard University (MD) |
Spouse(s) |
Gregory Petsko |
Children | 3, including Jake Auchincloss |
Father | Melvin J. Glimcher |
Awards | William B. Coley Award (2012) |
Scientific career | |
Fields | Cancer immunotherapy |
Institutions | Harvard Medical School Dana–Farber Cancer Institute |
Laurie Hollis Glimcher (born 1951) is an American physician-scientist and former President and CEO of Dana–Farber Cancer Institute.[1] She was elected a member of the American Philosophical Society in 2019.[citation needed] Glimcher has been at the center of controversies related to animal rights activists,[2] excessive corporate payments,[3] and research misconduct.[4] A 2021 investigation by the Boston Globe Spotlight team highlighted Glimcher’s activities on multiple corporate boards, including Bristol Myers Squibb, GlaxoSmithKline, and Analog Devices.[5] After this investigation, Glimcher continued to receive compensation on for-profit boards, while doubling her salary to $4 million per year at Dana-Farber.[6] In October 2024, Glimcher stepped down as President and CEO of Dana-Farber.[7]